J&J reports $100M in first-quarter COVID-19 vaccine sales
Clip: 04/20/2021 | 2m 42s | Video has closed captioning.
The disclosure was made in its quarterly earnings report, which also showed the New Brunswick-based company’s revenue and earnings beat expectations. Johnson & Johnson said that it's working to restore confidence in its vaccine.
Problems Playing Video? | Closed Captioning